Paper35933332
Systematic review of circulating MICRORNAS as biomarkers of cervical carcinogenesis.
Nascimento NPG and 4 others. BMC Cancer, 2022. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Systematic review of circulating MICRORNAS as biomarkers of cervical carcinogenesis. Papers, record 35933332. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35933332
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Circulating MicroRNA | Major topic |
| MicroRNAs | Major topic |
| Uterine Cervical Neoplasms | Major topic |
| Biomarkers | |
| Biomarkers, Tumor | |
| Carcinogenesis | |
| Early Detection of Cancer | |
| Female | |
| Humans |
Source PubMed
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31590680 | Serum and tissue miRNAs: potential biomarkers for the diagnosis of cervical cancer. | Virol J | 2019 | https://conductscience.org/library/papers/31590680 | PubMed |
| 2 | 22007046 | QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. | Ann Intern Med | 2011 | https://conductscience.org/library/papers/22007046 | PubMed |
| 3 | 12807943 | Chapter 5: Viral and host factors in human papillomavirus persistence and progression. | J Natl Cancer Inst Monogr | 2003 | https://conductscience.org/library/papers/12807943 | PubMed |
| 4 | 30261286 | MiR-1266 promotes cell proliferation, migration and invasion in cervical cancer by targeting DAB2IP. | Biochim Biophys Acta Mol Basis Dis | 2018 | https://conductscience.org/library/papers/30261286 | PubMed |
| 5 | 15183049 | Classification of papillomaviruses. | Virology | 2004 | https://conductscience.org/library/papers/15183049 | PubMed |
| 6 | 34086555 | MicroRNA Levels in Cervical Cancer Samples and Relationship with Lesion Grade and HPV Infection. | Microrna | 2021 | https://conductscience.org/library/papers/34086555 | PubMed |
| 7 | 26656154 | Serum miRNAs panel (miR-16-2*, miR-195, miR-2861, miR-497) as novel non-invasive biomarkers for detection of cervical cancer. | Sci Rep | 2015 | https://conductscience.org/library/papers/26656154 | PubMed |
| 8 | 20146939 | Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). | Methods | 2010 | https://conductscience.org/library/papers/20146939 | PubMed |
| 9 | 30940131 | Exosomal let-7d-3p and miR-30d-5p as diagnostic biomarkers for non-invasive screening of cervical cancer and its precursors. | Mol Cancer | 2019 | https://conductscience.org/library/papers/30940131 | PubMed |
| 10 | 26171195 | Expression profile of circulating microRNAs as a promising fingerprint for cervical cancer diagnosis and monitoring. | Mol Clin Oncol | 2015 | https://conductscience.org/library/papers/26171195 | PubMed |
| 11 | 28182350 | Diagnostic Value of Serum hsa-mir-92a in Patients with Cervical Cancer. | Clin Lab | 2017 | https://conductscience.org/library/papers/28182350 | PubMed |
| 12 | 33990639 | Urine miRNA signature as a potential non-invasive diagnostic and prognostic biomarker in cervical cancer. | Sci Rep | 2021 | https://conductscience.org/library/papers/33990639 | PubMed |
| 13 | 29945565 | MicroRNAs as markers of progression in cervical cancer: a systematic review. | BMC Cancer | 2018 | https://conductscience.org/library/papers/29945565 | PubMed |
| 14 | 33327867 | A Novel Circulating MiRNA-Based Signature for the Diagnosis and Prognosis Prediction of Early-Stage Cervical Cancer. | Technol Cancer Res Treat | 2020 | https://conductscience.org/library/papers/33327867 | PubMed |
| 15 | 33112434 | Circulating miR-15b, miR-34a and miR-218 as promising novel early low-invasive biomarkers of cervical carcinogenesis. | APMIS | 2021 | https://conductscience.org/library/papers/33112434 | PubMed |
| 16 | 16949995 | Chapter 1: HPV in the etiology of human cancer. | Vaccine | 2006 | https://conductscience.org/library/papers/16949995 | PubMed |
| 17 | 28534701 | Plasma miR-145 as a novel biomarker for the diagnosis and radiosensitivity prediction of human cervical cancer. | J Int Med Res | 2017 | https://conductscience.org/library/papers/28534701 | PubMed |
| 18 | 31873160 | Identification of miR-328-3p as an endogenous reference gene for the normalization of miRNA expression data from patients with Diabetic Retinopathy. | Sci Rep | 2019 | https://conductscience.org/library/papers/31873160 | PubMed |
| 19 | 19621072 | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. | PLoS Med | 2009 | https://conductscience.org/library/papers/19621072 | PubMed |
| 20 | 16174218 | Human papillomavirus infection: biology, epidemiology, and prevention. | Int J Gynecol Cancer | 2005 | https://conductscience.org/library/papers/16174218 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42653020 | MicroRNA Dysregulation in HPV-Driven Cervical Cancer: A Review of Oncoprotein-Targeted Signaling Pathways. | Life (Basel) | 2026 | https://conductscience.org/library/papers/42653020 | PubMed |
| 42353050 | MicroRNAs as Biomarkers of Cervical Cancers. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353050 | PubMed |
| 42350562 | Systematic assessment for potential endogenous normalizers for microRNA analysis in fecal samples. | Sci Rep | 2026 | https://conductscience.org/library/papers/42350562 | PubMed |
| 42121949 | Circulating microRNA Profiles as Diagnostic Tools for High-Grade Cervical Lesions and HPV Genotype Stratification. | Cells | 2026 | https://conductscience.org/library/papers/42121949 | PubMed |
| 41749813 | MicroRNA-Based Triage of HPV-Positive Women Using Liquid-Based Cytology: Diagnostic Performance and Network-Level Insights. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41749813 | PubMed |
| 41562703 | Upregulation of a MicroRNA Signature Involving miR-17-5p, miR-26b-5p, miR-106a-5p, and miR-146a-5p During Cervical Epithelial Transformation. | Epigenomes | 2025 | https://conductscience.org/library/papers/41562703 | PubMed |
| 41516135 | Differentially Expressed Genes Associated with the Development of Cervical Cancer. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41516135 | PubMed |
| 41226541 | Liquid Biopsy Biomarkers for Cervical Cancer: A Systematic Review. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41226541 | PubMed |
| 40695852 | Identification of SnRNA U6 as an endogenous reference gene for normalization of MiRNA expression data in COVID-19 patients. | Sci Rep | 2025 | https://conductscience.org/library/papers/40695852 | PubMed |
| 39519256 | Utilization of miRNAs as Biomarkers for the Diagnosis, Prognosis, and Metastasis in Gynecological Malignancies. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39519256 | PubMed |
| 38939506 | The diagnostic accuracy of serum and plasma microRNAs in detection of cervical intraepithelial neoplasia and cervical cancer: A systematic review and meta-analysis. | Gynecol Oncol Rep | 2024 | https://conductscience.org/library/papers/38939506 | PubMed |
| 38832007 | Hallmarks of cancer resistance. | iScience | 2024 | https://conductscience.org/library/papers/38832007 | PubMed |
| 38749770 | Performance of an ancillary test for cervical cancer that measures miRNAs and cytokines in serum and cervical mucus. | Cancer Sci | 2024 | https://conductscience.org/library/papers/38749770 | PubMed |
| 37810963 | Molecular triaging options for women testing HPV positive with self-collected samples. | Front Oncol | 2023 | https://conductscience.org/library/papers/37810963 | PubMed |
| 37298066 | NOVAprep-miR-Cervix: New Method for Evaluation of Cervical Dysplasia Severity Based on Analysis of Six miRNAs. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37298066 | PubMed |
| 36908850 | miR-19-3p Targets PTEN to Regulate Cervical Cancer Cell Proliferation, Invasion, and Autophagy. | Genet Res (Camb) | 2023 | https://conductscience.org/library/papers/36908850 | PubMed |
| 36555361 | Cancer-Specific miRNAs Extracted from Tissue-Exudative Extracellular Vesicles in Ovarian Clear Cell Carcinoma. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36555361 | PubMed |
Genes36
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35933332
GET https://conductscience.org/api/papers/v1/35933332/references?page=2